loadpatents
name:-0.028561115264893
name:-0.018216848373413
name:-0.00049591064453125
Young; Aiping H. Patent Filings

Young; Aiping H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Young; Aiping H..The latest application filed is for "2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer".

Company Profile
0.18.27
  • Young; Aiping H. - Toronto CA
  • Young; Aiping H. - North York CA
  • YOUNG; Aiping H. - Ontario CA
  • Young; Aiping H. - Winnipeg CA
  • Young, Aiping H. - North York Ontario CA
  • Young, Aiping H - Ontario CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Aryl imidazoles and their use as anti-cancer agents
Grant 10,080,739 - Huesca , et al. September 25, 2
2018-09-25
2-substituted Imidazo[4,5-d]phenanthroline Derivatives And Their Use In The Treatment Of Cancer
App 20160176876 - LEE; Yoon ;   et al.
2016-06-23
2-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the treatment of cancer
Grant 9,309,247 - Lee , et al. April 12, 2
2016-04-12
2-substituted Imidazo[4,5-d]phenanthroline Derivatives And Their Use In The Treatment Of Cancer
App 20160031883 - LEE; Yoon ;   et al.
2016-02-04
Aryl Imidazoles And Their Use As Anti-cancer Agents
App 20150374669 - HUESCA; Mario ;   et al.
2015-12-31
2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
Grant 8,987,305 - Al-Qawasmeh , et al. March 24, 2
2015-03-24
Aryl imidazoles and their use as anti-cancer agents
Grant 8,969,372 - Huesca , et al. March 3, 2
2015-03-03
2,4,5-trisubstituted Imidazoles And Their Use As Anti-microbial Agents
App 20130177632 - Al-Qawasmeh; Raed H. ;   et al.
2013-07-11
2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
Grant 8,394,815 - Al-Qawasmeh , et al. March 12, 2
2013-03-12
Use of interleukin 17E for the treatment of cancer
Grant 8,287,851 - Wright , et al. October 16, 2
2012-10-16
2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer
Grant 8,148,392 - Huesca , et al. April 3, 2
2012-04-03
Use Of Interleukin 17e For The Treatment Of Cancer
App 20110158936 - Wright; Jim A. ;   et al.
2011-06-30
Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer
Grant 7,968,526 - Wright , et al. June 28, 2
2011-06-28
2,4,5-trisubstituted Imidazoles And Their Use As Anti-microbial Agents
App 20110152337 - AL-QAWASMEH; RAED H. ;   et al.
2011-06-23
Combination Preparation Of A Biological Response Modifier And An Anticancer Agent And Uses Thereof
App 20110111047 - YOUNG; Aiping H.
2011-05-12
2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
Grant 7,884,120 - Al-Qawasmeh , et al. February 8, 2
2011-02-08
Small Interfering Rna Molecules Against Ribonucleotide Reductase And Uses Thereof
App 20100204305 - YOUNG; Aiping H. ;   et al.
2010-08-12
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and Uses Thereof in the Treatment of Cancer
App 20100197766 - WRIGHT; Jim A. ;   et al.
2010-08-05
2-Indolyl Imidazo [4,5-d] Phenanthroline Derivatives and Their Use in the Treatment for Cancer
App 20100168417 - Huesca; Mario ;   et al.
2010-07-01
Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2 and Uses Thereof in Combination Therapies for the Treatment of Cancer
App 20080311126 - Young; Aiping H. ;   et al.
2008-12-18
Combination Preparation of a Biological Response Modifier and an Anticancer Agent and Uses Thereof
App 20080279818 - Young; Aiping H.
2008-11-13
Aryl imidazoles and their use as anti-cancer agents
App 20080262015 - Huesca; Mario ;   et al.
2008-10-23
Small Interfering Rna Molecules Against Ribonucleotide Reductase and Uses Thereof
App 20080255065 - Young; Aiping H. ;   et al.
2008-10-16
Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
Grant 7,405,205 - Wright , et al. July 29, 2
2008-07-29
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1 and Uses Thereof in the Treatment of Cancer
App 20070274947 - Young; Aiping H. ;   et al.
2007-11-29
Aryl imidazoles and their use as anti-cancer agents
App 20070123553 - Huesca; Mario ;   et al.
2007-05-31
Oligonucleotides from the untranslated regions of housekeeping genes and methods of using same to modulate cell growth
Grant 7,223,849 - Wright , et al. May 29, 2
2007-05-29
Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cells
App 20070032442 - Wright; Jim A. ;   et al.
2007-02-08
Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
Grant 7,087,580 - Wright , et al. August 8, 2
2006-08-08
Combination preparation of a biological response modifier and an anticancer agent and uses thereof
App 20060034938 - Young; Aiping H.
2006-02-16
Biological response modifier for the treatment of cancer
App 20050192443 - Young, Aiping H.
2005-09-01
Biological response modifier composition and uses thereof
App 20040198819 - Young, Aiping H.
2004-10-07
Combination preparation of a biological response modifier and an anticancer agent and uses thereof
App 20040101511 - Young, Aiping H
2004-05-27
Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
App 20040009948 - Wright, Jim A. ;   et al.
2004-01-15
Antisense oligonucleotide sequences as inhibitors of microorganisms
Grant 6,610,539 - Wright , et al. August 26, 2
2003-08-26
Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
Grant 6,566,514 - Wright , et al.
2003-05-20
Suppression of malignancy utilizing ribonucleotide reductase R1
App 20030087866 - Wright, Jim A. ;   et al.
2003-05-08
Neuropilin Antisense Oligonucleotide Sequences And Methods Of Using Same To Modulate Cell Growth
App 20030083274 - WRIGHT, JIM A. ;   et al.
2003-05-01
Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growth
App 20020187954 - Wright, Jim A. ;   et al.
2002-12-12
Supression Of Malignancy Utilizing Ribonucleotide Reductase R1
App 20020004488 - WRIGHT, JIM A. ;   et al.
2002-01-10
Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
Grant 6,121,000 - Wright , et al. September 19, 2
2000-09-19
Antitumor antisense sequences directed against ribonucleotide reductase
Grant 5,998,383 - Wright , et al. December 7, 1
1999-12-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed